Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension.

[1]  A. Matsumori,et al.  Endothelin antagonism with bosentan: current status and future perspectives. , 2006, Cardiovascular drug reviews.

[2]  I. Fantozzi,et al.  Hypoxia increases AP-1 binding activity by enhancing capacitative Ca2+ entry in human pulmonary artery endothelial cells. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[3]  N. Voelkel,et al.  Circulating endothelial cells in pulmonary hypertension , 2003, Thrombosis and Haemostasis.

[4]  P. Thistlethwaite,et al.  Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  K. Brown,et al.  Expression of human herpesvirus 8 in primary pulmonary hypertension. , 2003, The New England journal of medicine.

[6]  I. Fantozzi,et al.  Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[7]  S. Eddahibi,et al.  Role of VEGF-B in the lung during development of chronic hypoxic pulmonary hypertension. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[8]  D. Stewart,et al.  Protective Role of Angiopoietin-1 in Experimental Pulmonary Hypertension , 2003, Circulation research.

[9]  G. Yancopoulos,et al.  Angiopoietin-1 and pulmonary hypertension: cause or cure? , 2003, Circulation research.

[10]  P. Thistlethwaite,et al.  Signaling molecules in nonfamilial pulmonary hypertension. , 2003, The New England journal of medicine.

[11]  Ying Yu,et al.  PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression. , 2003, American journal of physiology. Cell physiology.

[12]  Lan Zhao,et al.  Beneficial Effects of Phosphodiesterase 5 Inhibition in Pulmonary Hypertension Are Influenced by Natriuretic Peptide Activity , 2003, Circulation.

[13]  R. Nemenoff,et al.  Hypoxic activation of adventitial fibroblasts: role in vascular remodeling. , 2002, Chest.

[14]  H. Stein,et al.  Aberrantly expressed c‐Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF‐κB , 2002, The EMBO journal.

[15]  R. Barst,et al.  Bosentan therapy for pulmonary arterial hypertension. , 2002, The New England journal of medicine.

[16]  Anja Nohe,et al.  The Mode of Bone Morphogenetic Protein (BMP) Receptor Oligomerization Determines Different BMP-2 Signaling Pathways* , 2002, The Journal of Biological Chemistry.

[17]  A. Chiavegato,et al.  Contribution of Adventitial Fibroblasts to Neointima Formation and Vascular Remodeling: From Innocent Bystander to Active Participant , 2001, Circulation research.

[18]  J. Morrow,et al.  Increased levels of prostaglandin D(2) suggest macrophage activation in patients with primary pulmonary hypertension. , 2001, Chest.

[19]  M. Humbert,et al.  Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. , 2001, The Journal of clinical investigation.

[20]  N. Voelkel,et al.  The pathobiology of pulmonary hypertension. Endothelium. , 2001, Clinics in chest medicine.

[21]  R. Trembath,et al.  Altered Growth Responses of Pulmonary Artery Smooth Muscle Cells From Patients With Primary Pulmonary Hypertension to Transforming Growth Factor-&bgr;1 and Bone Morphogenetic Proteins , 2001, Circulation.

[22]  M. Humbert,et al.  Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. , 2001, The New England journal of medicine.

[23]  John Arul Phillips,et al.  Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred. , 2001, The New England journal of medicine.

[24]  P. Thistlethwaite,et al.  Human angiopoietin gene expression is a marker for severity of pulmonary hypertension in patients undergoing pulmonary thromboendarterectomy. , 2001, The Journal of thoracic and cardiovascular surgery.

[25]  Ying Yu,et al.  Bcl-2 decreases voltage-gated K+ channel activity and enhances survival in vascular smooth muscle cells. , 2001, American journal of physiology. Cell physiology.

[26]  D. Mottet,et al.  HIF‐1 and AP‐1 Cooperate to Increase Gene Expression in Hypoxia: Role of MAP Kinases , 2001, IUBMB life.

[27]  Thomas A. Mustoe, MD, FACS,et al.  Oxygen in wound healing: More than a nutrient , 2001, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[28]  Wei-wei Wang,et al.  Dexfenfluramine as a mitogen signals through the formation of superoxide anion , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  Michael R. Pinsky,et al.  Respiratory-circulatory interactions in health and disease , 2001 .

[30]  O. Platoshyn,et al.  Activation of K+ channels induces apoptosis in vascular smooth muscle cells. , 2001, American journal of physiology. Cell physiology.

[31]  P. Aaronson,et al.  Hypoxia induces the release of a pulmonary-selective, Ca(2+)-sensitising, vasoconstrictor from the perfused rat lung. , 2001, Cardiovascular research.

[32]  M. Hamon,et al.  Dexfenfluramine-associated changes in 5-hydroxytryptamine transporter expression and development of hypoxic pulmonary hypertension in rats. , 2001, The Journal of pharmacology and experimental therapeutics.

[33]  N. Voelkel,et al.  Gene Expression Patterns in the Lungs of Patients With Primary Pulmonary Hypertension: A Gene Microarray Analysis , 2001, Circulation research.

[34]  H. Ohira,et al.  Effect of a serotonin receptor antagonist on interleukin-6-induced pulmonary hypertension in rats. , 2001, Chest.

[35]  P. Hirth,et al.  Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  C. L. Bailey,et al.  Upregulated TRP and enhanced capacitative Ca(2+) entry in human pulmonary artery myocytes during proliferation. , 2001, American journal of physiology. Heart and circulatory physiology.

[37]  Sakae Tanaka,et al.  Negative Regulation of BMP/Smad Signaling by Tob in Osteoblasts , 2000, Cell.

[38]  H. Lodish,et al.  Critical Role of Smads and AP-1 Complex in Transforming Growth Factor-β-dependent Apoptosis* , 2000, The Journal of Biological Chemistry.

[39]  G. Semenza.  Oxygen-regulated transcription factors and their role in pulmonary disease , 2000, Respiratory research.

[40]  M. Gatzoulis,et al.  Sildenafil in primary pulmonary hypertension. , 2000, The New England journal of medicine.

[41]  C. L. Bailey,et al.  Sustained membrane depolarization and pulmonary artery smooth muscle cell proliferation. , 2000, American journal of physiology. Cell physiology.

[42]  P. Friedman,et al.  Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study. , 2000, American journal of respiratory and critical care medicine.

[43]  S. Hodge,et al.  Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. , 2000, American journal of human genetics.

[44]  M. Maclean,et al.  5‐hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension , 2000, British journal of pharmacology.

[45]  Y Ishizaki,et al.  Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[46]  A. Hislop,et al.  Prenatal origins of human intrapulmonary arteries: formation and smooth muscle maturation. , 2000, American journal of respiratory cell and molecular biology.

[47]  K. Lesch,et al.  Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. , 2000, The Journal of clinical investigation.

[48]  R. Rothman,et al.  Chronic treatment with phentermine combined with fenfluramine lowers plasma serotonin. , 2000, The American journal of cardiology.

[49]  J. Massagué,et al.  Controlling TGF-β signaling , 2000, Genes & Development.

[50]  G. Kay,et al.  Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. , 2000, Circulation research.

[51]  J. Berkenbosch,et al.  Decreased synthesis and vasodilation to nitric oxide in piglets with hypoxia-induced pulmonary hypertension. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[52]  J. Massagué,et al.  OAZ Uses Distinct DNA- and Protein-Binding Zinc Fingers in Separate BMP-Smad and Olf Signaling Pathways , 2000, Cell.

[53]  K. Alitalo,et al.  Current biology of VEGF-B and VEGF-C. , 1999, Current opinion in biotechnology.

[54]  R. Weinberg,et al.  SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[55]  J. Darnell,et al.  Interacting Regions in Stat3 and c-Jun That Participate in Cooperative Transcriptional Activation , 1999, Molecular and Cellular Biology.

[56]  R. Rothman,et al.  Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension. , 1999, Circulation.

[57]  K. Münter,et al.  Endothelin-1 and endothelin receptor antagonists in cardiovascular remodeling. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[58]  R. L. Williams,et al.  Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. , 1999, The American journal of pathology.

[59]  Wei-wei Wang,et al.  Serotonin stimulates mitogen-activated protein kinase activity through the formation of superoxide anion. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[60]  C. Bortner,et al.  Caspase Independent/Dependent Regulation of K+, Cell Shrinkage, and Mitochondrial Membrane Potential during Lymphocyte Apoptosis* , 1999, The Journal of Biological Chemistry.

[61]  M. Blaustein,et al.  Sodium/calcium exchange: its physiological implications. , 1999, Physiological reviews.

[62]  K. Yamato,et al.  Differential Inhibition of Smad6 and Smad7 on Bone Morphogenetic Protein- and Activin-mediated Growth Arrest and Apoptosis in B Cells* , 1999, The Journal of Biological Chemistry.

[63]  J. Massagué,et al.  A Smad Transcriptional Corepressor , 1999, Cell.

[64]  D. Rodman,et al.  Hypoxia inhibits increased ETB receptor-mediated NO synthesis in hypertensive rat lungs. , 1999, The American journal of physiology.

[65]  M. Martres,et al.  Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin. , 1999, Circulation research.

[66]  Louis Wj.  Primary pulmonary hypertension and anorectic drugs. , 1999 .

[67]  G. Garcı́a-Cardeña,et al.  Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[68]  A. Fishman.  Aminorex to fen/phen: an epidemic foretold. , 1999, Circulation.

[69]  D. Faller.  ENDOTHELIAL CELL RESPONSES TO HYPOXIC STRESS , 1999, Clinical and experimental pharmacology & physiology.

[70]  A. Lopes,et al.  Circulating von Willebrand factor antigen as a predictor of short-term prognosis in pulmonary hypertension. , 1998, Chest.

[71]  J. Orens,et al.  Dysfunctional voltage-gated K+ channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension. , 1998, Circulation.

[72]  R. Yen,et al.  Comparison of Theory and Experiment in Pulsatile Flow in Cat Lung , 1998, Annals of Biomedical Engineering.

[73]  M. Rabinovitch,et al.  Elastase and the pathobiology of unexplained pulmonary hypertension. , 1998, Chest.

[74]  A. Giaid.  Nitric oxide and endothelin-1 in pulmonary hypertension. , 1998, Chest.

[75]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[76]  J. Yuan,et al.  Action of fenfluramine on voltage- gated K+ channels in human pulmonary-artery smooth-muscle cells , 1998, The Lancet.

[77]  S. Kourembanas,et al.  Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. , 1998, American journal of respiratory cell and molecular biology.

[78]  Keli Xu,et al.  Calcium oscillations increase the efficiency and specificity of gene expression , 1998, Nature.

[79]  C. Boshoff,et al.  Human herpesvirus type 8 and Kaposi's sarcoma. , 1998, Journal of the National Cancer Institute. Monographs.

[80]  R. Goldie.  Endothelin receptor subtypes: distribution and function in the lung. , 1998, Pulmonary pharmacology & therapeutics.

[81]  M. Juhaszova,et al.  Attenuated K+ channel gene transcription in primary pulmonary hypertension , 1998, The Lancet.

[82]  K. Shroyer,et al.  Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. , 1998, The Journal of clinical investigation.

[83]  B. Fanburg,et al.  Superoxide as an intermediate signal for serotonin-induced mitogenesis. , 1998, Free radical biology & medicine.

[84]  Y. Tsujimoto,et al.  Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[85]  H. Bading,et al.  Mechanisms controlling gene expression by nuclear calcium signals. , 1998, Cell calcium.

[86]  J. Massagué,et al.  Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. , 1998, Genes & development.

[87]  C. Bortner,et al.  A Primary Role for K+ and Na+ Efflux in the Activation of Apoptosis* , 1997, The Journal of Biological Chemistry.

[88]  Kohei Miyazono,et al.  TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.

[89]  M. Berridge,et al.  Nuclear calcium signalling by individual cytoplasmic calcium puffs , 1997, The EMBO journal.

[90]  K. Miyazono,et al.  Smad6 inhibits signalling by the TGF-β superfamily , 1997, Nature.

[91]  R. Penner,et al.  Store depletion and calcium influx. , 1997, Physiological reviews.

[92]  Huiling He,et al.  Maintenance of Calcium Homeostasis in the Endoplasmic Reticulum by Bcl-2 , 1997, The Journal of cell biology.

[93]  P. Huang,et al.  Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene. , 1997, Circulation research.

[94]  D. Sawyer,et al.  Early fetal development of lung vasculature. , 1997, American journal of respiratory cell and molecular biology.

[95]  B. Fanburg,et al.  A new role for an old molecule: serotonin as a mitogen. , 1997, The American journal of physiology.

[96]  K. Stenmark,et al.  Hypoxia increases bromodeoxyuridine labeling indices in bovine neonatal pulmonary arteries. , 1997, American journal of respiratory cell and molecular biology.

[97]  N. Voelkel,et al.  Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. , 1997, Human pathology.

[98]  K. McQuaid,et al.  Endothelial barrier dysfunction and oxidative stress: roles for nitric oxide? , 1997, Experimental physiology.

[99]  T. Evans,et al.  Nitric oxide, the biological mediator of the decade: fact or fiction? , 1997, The European respiratory journal.

[100]  D. Green,et al.  The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.

[101]  Hilmar Bading,et al.  Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression , 1997, Nature.

[102]  R. Yen,et al.  Morphometry of the human pulmonary vasculature. , 1996, Journal of applied physiology.

[103]  M. Houslay,et al.  5‐Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats , 1996, British journal of pharmacology.

[104]  R. Marlar,et al.  Coagulation and fibrinolytic profiles in patients with severe pulmonary hypertension. , 1996, Chest.

[105]  Lieve Moons,et al.  Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele , 1996, Nature.

[106]  X. J. Yuan,et al.  Voltage-gated K+ currents regulate resting membrane potential and [Ca2+]i in pulmonary arterial myocytes. , 1995, Circulation research.

[107]  A Giaid,et al.  Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. , 1995, The New England journal of medicine.

[108]  M. Nelson,et al.  Physiological roles and properties of potassium channels in arterial smooth muscle. , 1995, The American journal of physiology.

[109]  N. Voelkel,et al.  Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. , 1995, The Journal of clinical investigation.

[110]  N. Allbritton,et al.  Source of nuclear calcium signals. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[111]  Andrew P. Somlyo,et al.  Signal transduction and regulation in smooth muscle , 1994, Nature.

[112]  Carl Nathan,et al.  Nitric oxide synthases: Roles, tolls, and controls , 1994, Cell.

[113]  T. Saruta,et al.  Pressure promotes DNA synthesis in rat cultured vascular smooth muscle cells. , 1994, The Journal of clinical investigation.

[114]  M. Yanagisawa.  The endothelin system. A new target for therapeutic intervention. , 1994, Circulation.

[115]  B. Groves,et al.  Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. , 1994, The American journal of pathology.

[116]  G S Kassab,et al.  Diameter-defined Strahler system and connectivity matrix of the pulmonary arterial tree. , 1994, Journal of applied physiology.

[117]  Y. Fung,et al.  Material coefficients of the strain energy function of pulmonary arteries in normal and cigarette smoke-exposed rats. , 1993, Journal of biomechanics.

[118]  H. Mogami,et al.  Stimulation of calcium entry is prerequisite for DNA synthesis induced by platelet-derived growth factor in vascular smooth muscle cells. , 1993, Biochemical and biophysical research communications.

[119]  G. Isenberg,et al.  Membrane potential modulates inositol 1,4,5‐trisphosphate‐mediated Ca2+ transients in guinea‐pig coronary myocytes. , 1993, The Journal of physiology.

[120]  P. Barnes,et al.  Nitric oxide and lung disease. , 1993, Thorax.

[121]  Y C Fung,et al.  Changes in the structure and mechanical properties of pulmonary arteries of rats exposed to cigarette smoke. , 1993, The American review of respiratory disease.

[122]  G S Kassab,et al.  Morphometry of the dog pulmonary venous tree. , 1993, Journal of applied physiology.

[123]  M. Blaustein,et al.  Physiological effects of endogenous ouabain: control of intracellular Ca2+ stores and cell responsiveness. , 1993, The American journal of physiology.

[124]  E. Oldfield,et al.  Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. , 1993, The American journal of physiology.

[125]  M. Berridge.  Inositol trisphosphate and calcium signalling , 1993, Nature.

[126]  Y C Fung,et al.  Changes in the rheological properties of blood vessel tissue remodeling in the course of development of diabetes. , 1992, Biorheology.

[127]  B. Groves,et al.  An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. , 1992, The New England journal of medicine.

[128]  Y. Fung,et al.  Influence of STZ-Induced Diabetes on Zero-Stress States of Rat Pulmonary and Systemic Arteries , 1992, Diabetes.

[129]  Y C Fung,et al.  Changes of zero-stress state of rat pulmonary arteries in hypoxic hypertension. , 1991, Journal of applied physiology.

[130]  B. Marshall,et al.  Hypoxic contraction of cultured pulmonary vascular smooth muscle cells. , 1990, American journal of respiratory cell and molecular biology.

[131]  A. Jaffe,et al.  Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension. , 1990, Circulation.

[132]  M. Blaustein,et al.  Contrasting effects of hypoxia on tension in rat pulmonary and mesenteric arteries. , 1990, The American journal of physiology.

[133]  J. Vane,et al.  Regulatory functions of the vascular endothelium. , 1990, The New England journal of medicine.

[134]  J B Patlak,et al.  Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. , 1990, The American journal of physiology.

[135]  B. Madden,et al.  The ultrastructure of plexogenic pulmonary arteriopathy , 1990, The Journal of pathology.

[136]  B. Fanburg,et al.  Serotonin uptake and configurational change of bovine pulmonary artery smooth muscle cells in culture , 1989, Journal of cellular physiology.

[137]  L. Rubin,et al.  Primary pulmonary hypertension. , 1997, The New England journal of medicine.

[138]  L. Hoyer,et al.  von Willebrand factor abnormalities in primary pulmonary hypertension. , 1987, The American review of respiratory disease.

[139]  K. Morgan,et al.  Stimulus‐specific patterns of intracellular calcium levels in smooth muscle of ferret portal vein. , 1984, The Journal of physiology.

[140]  Y C Fung,et al.  Morphometry of cat's pulmonary arterial tree. , 1984, Journal of biomechanical engineering.

[141]  Y C Fung,et al.  Analysis of blood flow in cat's lung with detailed anatomical and elasticity data. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

[142]  C. William Hall,et al.  Biomedical Engineering II Recent Developments , 1983 .

[143]  Y C Fung,et al.  Morphometry of cat pulmonary venous tree. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

[144]  R. Michel,et al.  Partitioning of pulmonary vascular resistance in dogs by arterial and venous occlusion. , 1982, Journal of applied physiology: respiratory, environmental and exercise physiology.

[145]  Y. Fung,et al.  Biomechanics: Mechanical Properties of Living Tissues , 1981 .

[146]  B. Zweifach,et al.  Pre- and postcapillary resistances in cat mesentery. , 1974, Microvascular research.

[147]  G Cumming,et al.  Morphometry of the Human Pulmonary Arterial Tree , 1973, Circulation research.

[148]  Y C Fung,et al.  Elasticity of the Pulmonary Alveolar Sheet , 1972, Circulation research.

[149]  Y. Fung,et al.  Pulmonary Alveolar Blood Flow , 1972, Circulation research.

[150]  Y C Fung,et al.  Theory of sheet flow in lung alveoli. , 1969, Journal of applied physiology.

[151]  A B DuBois,et al.  Longitudinal distribution of vascular resistance in the pulmonary arteries, capillaries, and veins. , 1968, The Journal of clinical investigation.

[152]  E. Weibel.  Morphometry of the Human Lung , 1965, Springer Berlin Heidelberg.

[153]  E. Weibel,et al.  Architecture of the Human Lung , 1962, Science.

[154]  A B DUBOIS,et al.  Mechanics of pulmonary circulation in isolated rabbit lungs. , 1959, The American journal of physiology.

[155]  P. Riederer,et al.  Organization of the human serotonin transporter gene , 2005, Journal of Neural Transmission / General Section JNT.

[156]  S. Archer,et al.  Hypoxic pulmonary vasoconstriction. , 2005, Journal of applied physiology.

[157]  J. Yuan.  Hypoxic pulmonary vasoconstriction : cellular and molecular mechanisms , 2004 .

[158]  A. Verin,et al.  Molecular Mechanisms of Thrombin-Induced Endothelial Cell Permeability , 2004, Biochemistry (Moscow).

[159]  Wei Huang,et al.  Tissue Remodeling of Rat Pulmonary Artery in Hypoxic Breathing. II. Course of Change of Mechanical Properties , 2004, Annals of Biomedical Engineering.

[160]  J. Yuan,et al.  Activation of K+ channels: an essential pathway in programmed cell death. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[161]  M. Humbert,et al.  BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. , 2001, American journal of human genetics.

[162]  J. Yuan,et al.  Pathophysiology of pulmonary hypertension , 2001 .

[163]  B. Fanburg,et al.  Association of Tyr phosphorylation of GTPase-activating protein with mitogenic action of serotonin. , 1997, The American journal of physiology.

[164]  阿部 博之,et al.  Data book on mechanical properties of living cells, tissues, and organs , 1996 .

[165]  A. Ruf,et al.  Ultrastructural aspects of platelet adhesion on subendothelial structures. , 1995, Seminars in thrombosis and hemostasis.

[166]  P. Aaronson,et al.  Hypoxic vasoconstriction and intracellular Ca2+ in pulmonary arteries: evidence for PKC-independent Ca2+ sensitization. , 1995, The American journal of physiology.

[167]  B. Fanburg,et al.  Serotonin produces both hyperplasia and hypertrophy of bovine pulmonary artery smooth muscle cells in culture. , 1994, The American journal of physiology.

[168]  P. Celada,et al.  Effects of chronic treatment with dexfenfluramine on serotonin in rat blood, brain and lung tissue. , 1994, Life sciences.

[169]  R. Crystal,et al.  The Lung: Scientific Foundations , 1991 .

[170]  R. N. Vaishnav,et al.  ESTIMATION OF RESIDUAL STRAINS IN AORTIC SEGMENTS , 1983 .